AUS
NZ
UK
CA
USA
IND
Health
CVS Health Corporation Approaching Dividend Deadline
October 16, 2024 02:23 PM PDT| By Team Kalkine MediaHighlights,CVS Health’s ex-dividend date is approaching this October.,The dividend is well-supported by both profits and cash flow.,CVS Health's earnings have remained stable, offering steady dividends.,CVS Health Corporation, a major player in the,h...
Overview of Pfizer's Q3 2024 Financial Performance Provided
October 16, 2024 02:26 AM PDT| By Team Kalkine MediaHighlights:,Upcoming Earnings Announcement:,Pfizer Inc. is scheduled to report its fiscal Q3 earnings results on Tuesday, October 29, with analysts projecting a profit of $0.62 per share, a significant turnaround from a loss in the same quarter last...
A 10.7% Surge Recorded for NovoCure (NVCR); Future Gains Speculated
October 16, 2024 02:05 AM PDT| By Team Kalkine MediaHighlights:,Significant Stock Surge:,NovoCure's shares rose by 10.7% to $17.78, driven by substantial trading volume following FDA approval of its Optune Lua device for metastatic non-small cell lung cancer.,Upcoming Earnings Report:,The company is p...
Is Zymeworks' Stock Surge Hinting at Future Success?
October 15, 2024 02:12 PM PDT| By Team Kalkine MediaHighlights,Zymeworks Inc. has seen its stock price rise significantly over the past year, despite reporting a decline in revenue, suggesting that market sentiment toward the company's potential has improved.,While Zymeworks has yet to generate profit...
Breakthrough For NeuroSense As ALS Treatment Nears Early Approval
October 15, 2024 02:09 PM PDT| By Team Kalkine MediaHighlights,NeuroSense Therapeutics is advancing its plans to file for early commercialization approval for PrimeC, an ALS treatment, under Health Canada's Notice of Compliance with Conditions (NOC/c) policy, following promising clinical trial results...
FDA Boosts Immuneering’s Pancreatic Cancer Breakthrough
October 15, 2024 02:04 PM PDT| By Team Kalkine MediaHighlights,Immuneering has secured orphan drug designation from the FDA for IMM-1-104, a promising therapy targeting pancreatic cancer, providing the company with regulatory incentives and marketing exclusivity advantages.,The orphan drug designation...
How Will ATAI Revolutionize Mental Health Treatments?
October 15, 2024 12:53 PM PDT| By Team Kalkine MediaHighlights,ATAI Life Sciences, a biopharmaceutical company focused on mental health treatments, is set to participate in the 2024 Maxim Healthcare Virtual Summit, highlighting its commitment to advancing mental health therapies.,The company’s co-CEO,...
Can Johnson & Johnson's Innovations Boost Growth?
October 15, 2024 12:46 PM PDT| By Team Kalkine MediaHighlights,Johnson & Johnson experienced a boost in shares following the release of its third-quarter results, highlighting robust performance across its pharmaceutical and medical devices sectors.,The company received regulatory approvals for key tr...
Highlights of Abbott's Q3 are being outlined
October 15, 2024 03:31 AM PDT| By Team Kalkine MediaHighlights:,Abbott is projected to report Q3 2024 revenue of $10.6 billion and adjusted earnings of $1.20 per share, aligning with market expectations.,Growth is anticipated across multiple segments, particularly driven by increased sales of the Free...
Innovative liposomal drug delivery platform by Lipella Pharmaceuticals has received U.S. patent allowance
October 15, 2024 02:29 AM PDT| By Team Kalkine MediaHighlights:,Lipella Pharmaceuticals has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its proprietary liposomal drug delivery platform.,The patent, titled 'Delivery of Agents Using Metastable Liposomes,...
Important developments in cancer treatment are being undertaken by IQ-AI
October 15, 2024 02:07 AM PDT| By Team Kalkine MediaHighlights:,IQ-AI Ltd is nearing completion of its Phase I clinical trial for IB003, a gallium maltolate therapy targeting children's brain cancer, with only two patients remaining for enrollment.,The company is preparing for a critical meeting with...
Cycle Pharmaceuticals Pushes for Vanda Acquisition Amid Struggles
October 14, 2024 03:18 PM PDT| By Team Kalkine MediaHighlights,Cycle Pharmaceuticals has reaffirmed its acquisition proposal for Vanda Pharmaceuticals, offering an all-cash deal that significantly values Vanda above its recent stock price, with the aim of expanding its presence in the pharmaceutical s...
NAYA Biosciences Emerges from INVO Merger with Expanded Focus
October 14, 2024 03:15 PM PDT| By Team Kalkine MediaHighlights,INVO Bioscience has successfully merged with NAYA Biosciences, forming a new entity that combines INVO's fertility business with NAYA's advancements in oncology and autoimmune disease therapies, operating under the name NAYA Biosciences.,T...
Integer Holdings Surges to New High Following Analyst Praise
October 14, 2024 01:25 PM PDT| By Team Kalkine MediaHeadlines,Integer Holdings achieves a new 1-year high after favorable analyst upgrades,Positive ratings from multiple analysts boost market confidence,Strong trading volume indicates heightened investor interest,Integer Holdings Co.,(NYSE:ITGR),has r...
Stryker's Growth Potential Highlighted by Analysts' Price Target Increases
October 14, 2024 12:37 PM PDT| By Team Kalkine MediaHeadlines,Stryker's Target Price Raised by Truist Financial,Multiple Analysts Weigh In on Stryker,Stryker Continues to Gain Attention from Analysts,Stryker,(NYSE:SYK),recently received a price target increase from research analysts at Truist Financia...
Owlet Regains NYSE Compliance: A Step Toward Financial Stability
October 14, 2024 08:45 AM PDT| By Team Kalkine MediaHeadlines,Owlet regains compliance with NYSE listing standards.,The company no longer faces compliance issues after meeting NYSE requirements.,Owlet enters a 12-month monitoring period for continued compliance.,Owlet,,(NYSE:OWLT),a company specializi...
AxoGen Shares Surge Amid Positive Sentiment
October 14, 2024 07:43 AM PDT| By Team Kalkine MediaHighlights,AxoGen's shares soared significantly in the last trading session, driven by positive market sentiment and increased trading volume, reflecting growing investor interest in the Healthcare sector.,The Federal Reserve's aggressive rate cut ha...
What Led to Bio-Rad Laboratories Shareholders Facing Losses Over the Past Three Years?
October 14, 2024 05:12 AM PDT| By Team Kalkine MediaHighlights:,Bio-Rad Laboratories, Inc.,(NYSE:BIO),operates in the healthcare and life sciences sector.,The stock experienced a decrease in value over the past three years.,The company's share price saw a decline in line with broader market trends.,Bi...
How Has Danaher Grown Over the Last Five Years?
October 14, 2024 05:08 AM PDT| By Team Kalkine MediaHighlights,Danaher Corporation operates within the medical and industrial equipment sectors.,The stock has experienced consistent long-term growth, particularly in the past five years.,Danaher’s market performance reflects its presence in various cri...
Phase III Study of Nasal Polyps Treatment Celebrated by GSK
October 14, 2024 05:03 AM PDT| By Team Kalkine MediaHighlights:,GSK PLC reports positive outcomes from two pivotal clinical trials (ANCHOR-1 and ANCHOR-2) evaluating depemokimab for chronic rhinosinusitis with nasal polyps (CRSwNP).,Participants receiving depemokimab demonstrated significant reduction...
